Skip to content

A Comparative Evaluation of EUS-Guided Biliary Drainage and Percutaneous Drainage in Patients with Malignant Biliary Obstruction after Failed ERCP: A Single-center Randomized Controlled Trial

A Comparative Evaluation of EUS-Guided Biliary Drainage and Percutaneous Drainage in Patients with Malignant Biliary Obstruction after Failed ERCP: A Single-center Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012615
Enrollment
Unknown
Registered
2017-09-07
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Biliary Obstruction

Interventions

percutaneous transhepaticcholangial drainage (PTCD) group:percutaneous transhepaticcholangial drainage (PTCD)
EUS-Guided Biliary Drainage (EUS-BD) group:EUS-Guided Biliary Drainage (EUS-BD)

Sponsors

Department of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years old; 2. Unresectable malignant biliary obstruction or have surgical indications, but refuse to surgery; 3. The failed ERCP; 4. Karnofsky index (body function condition assessment scale) 30% or higher; 5. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The expected lifespan is less than 1 month; 2. The acute stage of Gastrointestinal hemorrhage; 3. Can't correct blood coagulation dysfunction, 4. Can't tolerate anesthesia; 5. Don't agreed to participate in research; 6. Uncooperative patients judging by the researchers.

Design outcomes

Primary

MeasureTime frame
Technical success;

Secondary

MeasureTime frame
Clinical success;subsequent reinterventions;The quality of life score;

Countries

China

Contacts

Public ContactLei Wang

Department of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University, Medical School, Nanjing, China

867152094@qq.com+86 13851579216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026